HOME >> BIOLOGY >> NEWS
JCI table of contents: July 12, 2007

EDITOR'S PICK

Src inhibitors may prove beneficial in breast cancer therapy

Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alphanegative cancers are more aggressive and have a worse prognosis than do ER-alphapositive breast cancers, and have been thought to be estrogen independent. In a study appearing online on July 12 in advance of publication in the August print issue of the Journal of Clinical Investigation, Joyce Slingerland and colleagues from the University of Miami shed further light on the mechanisms regulating ER-alpha expression levels during breast cancer.

In their study of 250 primary breast cancers, the authors found that ER mRNA levels overlap considerably between ER-alphapositive and ER-alphanegative breast cancers. This lack of correlation between ER-alpha mRNA and protein levels pointed to the existence of important post-transcriptional control of ER-alpha expression. They found that ER-alphanegative primary breast cancers and cell lines showed increased levels and/or activity of the protein Src, which cooperates with estrogen to activate ER-alpha breakdown via proteolysis. In line with this finding, Src inhibition was shown to impair estrogen-stimulated ER-alpha proteolysis. The data raise the possibility that for at least a subset of ER-alphanegative breast cancers, Src may stimulate estrogen-dependent ER-alpha degradation, resulting in a lack of ER-alpha detection, and more aggressive tumor growth. The authors conclude that their study provides a rationale for the use of Src inhibitors in breast cancer therapy.

TITLE: Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer

AUTHOR CONTACT:
Joyce M. Slingerland
University of Miami Miller School of Medicine, Miami, Florida, USA.
Phone : (305) 243-7265;
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
12-Jul-2007


Page: 1 2 3 4 5

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: June 21, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... February 21, 2020 , ... Gateway Genomics , a leading developer of ... last year’s annual Inc. 5000 list of fastest-growing private companies in the ... to be the 17th fastest-growing private company in the state, and #1 in the ...
(Date:2/13/2020)... ... February 13, 2020 , ... Worldwide Business ... Nobio CEO Yoram Ashery to discuss how their revolutionary technology can kill ... bacteria to keep people healthy with their revolutionary nanoparticle technology. Nobio is on ...
(Date:2/7/2020)... ... , ... dicentra , a leading clinical research organization ... supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). , ... probiotics. We are thrilled to join our IPA member colleagues and bring sound ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... , ... February 21, 2020 , ... ... improve their manufacturing operations in order to adapt to new approaches like ‘Industry ... with the increasing demand for personalized medicine and therapies. But with an industry ...
(Date:2/11/2020)... (PRWEB) , ... February 11, ... ... company) is pleased to announce the successful results from a long-term follow-up ... using the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, ...
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation Travel ... Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All of ... the following statistics:, Average airfare price paid Domestically, ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in “instant ... today announced the availability of neuroscience of transformational leadership workshops. These highly interactive, ... of leadership and change research to become great transformational leaders. The workshops ...
Breaking Biology Technology:
Cached News: